Current Report



 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  08/21/2006
 
DRUGSTORE.COM, INC.
(Exact name of registrant as specified in its charter)
 
Commission File Number:  0-26137
 
DE
  
043416255
(State or other jurisdiction of
  
(IRS Employer
incorporation)
  
Identification No.)
 
411 108th Ave NE
Suite 1400
Bellevue, WA 98004
(Address of principal executive offices, including zip code)
 
(425) 372-3200
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Information to be included in the report

 
Item 1.01.    Entry into a Material Definitive Agreement
 
The board of directors of drugstore.com, inc. (the "Company") has approved changes to the Company's director compensation plan. The terms of the amended plan apply to the director appointed to the Company's board of directors on August 21, 2006, described under Item 5.02(d) of this report.

The terms of the amended director compensation plan are as follows:

Each eligible non-employee director who does not serve on behalf of an entity with a contractual right to a board seat (an "Eligible Non-Employee Director") will receive annual cash compensation in the amount of $5,000 for his or her service as a member of the board. Eligible Non-Employee Directors who serve as members of the audit committee will receive an additional $10,000 in annual compensation, and Eligible Non-Employee Directors who serve as members of any other committee will receive an additional $5,000 in annual compensation.

In addition, each Eligible Non-Employee Director will receive an initial grant of a non-statutory stock option to purchase 100,000 shares of the Company's common stock upon his or her election to the board (the "Initial Grant"), and an annual grant of a non-statutory option to purchase 30,000 shares of the Company's common stock for his or her service on the board during each one-year term following his or her election at the Company's annual meeting of stockholders ("Annual Grant"). Each Initial Grant will have an exercise price equal to the fair market value of the common stock on the date of grant and will vest over four years, with 20% vesting six months from the date of election and the remaining 80% vesting in equal quarterly increments over the remaining 42 months. Each Annual Grant will have an exercise price equal to the fair market value of the common stock on the date of grant and will fully vest on the one-year anniversary of the date of grant.

 
 
Item 5.02.    Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
(b) On August 21, 2006, Melinda French Gates resigned from the Company's board of directors.

(d) On August 21, 2006, Jeffrey Killeen was appointed to the Company's board of directors and to the Compensation Committee of the board. Mr. Killeen will receive the compensation for Eligible Non-Employee Directors described under Item 1.01 of this report.

Mr. Killeen is chairman and CEO of Global Spec Inc., a vertical search, information services and e-publishing company, and has more than 25 years of executive management experience in the media and information services industries. He serves on the boards of SkyTerra Corp., Dice Inc., The Center for the Disabled, and The Lake George Opera Co. Before joining GlobalSpec in 2002, he was CEO of Forbes.com and led the development of Forbes' portfolio of online financial information and electronic publishing businesses. He has also served in executive-level positions with Barnes & Noble.com, SBC/Pacific Bell, and Dun & Bradstreet.

 
 
Item 9.01.    Financial Statements and Exhibits
 
(c)    Exhibits

99.1        Press release dated August 21, 2006.

 

 

Signature(s)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
DRUGSTORE.COM, INC.
 
 
Date: August 23, 2006
     
By:
 
/s/    Dawn G. Lepore

               
Dawn G. Lepore
               
President, Chief Executive Officer and Chairman of the Board
 
 


 

Exhibit Index
 
Exhibit No.

  
Description

EX-99.1
  
Press Release dated August 21, 2006

 

drugstore.com, inc. Announces Changes to Board of Directors

 

BELLEVUE, Wash., Aug. 21, 2006 (BUSINESS WIRE) -- drugstore.com, inc. (Nasdaq:DSCM), a leading online provider of health, beauty, vision, and pharmacy products, today announced the appointment of Jeffrey Killeen, chairman and CEO of GlobalSpec Inc., to its board of directors, and the resignation of Melinda French Gates, co-chair of the Bill and Melinda Gates Foundation, from its board of directors.

 

Killeen, who joins the drugstore.com™ board today, has more than 25 years of executive management experience in the media, Internet and information services industries. He also serves on the board of SkyTerra Corp. Before joining GlobalSpec in 2002, Killeen was CEO of Forbes.com and led the development of Forbes' portfolio of online financial information and electronic publishing businesses. Before Forbes.com he was the COO of barnesandnoble.com, a major online retailer. He has also held executive-level positions with SBC/Pacific Bell and Dun & Bradstreet.

 

"We are delighted that Jeff has accepted our invitation to join the board and believe that Jeff's deep knowledge of online business and technology will play an important role in drugstore.com's success," said Dawn Lepore, chairman and CEO of drugstore.com, inc.

 

Over the past year, the company has made significant progress in growing both its revenues and its profit margins, Killeen said. "Since Dawn joined drugstore.com, they have focused on driving profitability and have gone through a succession of positive changes. I am looking forward to contributing to the company's long-term success."

 

Gates, who has been on the drugstore.com board since the company went public in 1999, resigned to spend more time on the work of the Bill & Melinda Gates Foundation. "I remain a strong supporter and plan to be a long-term shareholder in the company," said Gates.

 

"We have appreciated Melinda's long service to drugstore.com, and will miss her passion, dedication and business insights," said Lepore.

Other members of the drugstore.com board include Lepore; Dan Levitan, co-founder and managing partner of Maveron LLC; G. Charles "Cayce" Roy 3rd, vice president of Amazon.com, Inc.; William Savoy, former president of Vulcan, Inc.; and Gregory Stanger, executive in residence of Technology Crossover Ventures.

 

About drugstore.com, inc.

drugstore.com, inc. (Nasdaq:DSCM) is a leading online provider of health, beauty, vision, and pharmacy solutions. The drugstore.com™ online store provides a convenient, private, and informative shopping experience for consumers who seek products essential to healthy, everyday living. The online store offers thousands of brand-name personal health care products at competitive prices; a full-service, licensed retail pharmacy; and a wealth of health-related information, buying guides, and other tools designed to help consumers make informed purchasing decisions. Consumers can personalize their shopping experiences with shopping lists; e-mail reminders for replenishing regularly used products, and private e-mail access to pharmacists and beauty experts for questions.

As a fully licensed facility exercising competent, safe pharmacy practices in compliance with federal and state laws and regulations, the drugstore.com™ pharmacy has been awarded the Verified Internet Pharmacy Practice Sites certification by the National Association of Boards of Pharmacy.

 

Contact:

drugstore.com, inc.
Nina Bondarook, 425-372-3412
nbondarook@drugstore.com